COMPLETED

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

Talk to us

Conditions

BD Prevue II for Peripheral Intravenous Catheter Placement

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

Official Title

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

Quick Facts

Study Start:2025-03-28
Study Completion:2025-09-23
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06632496

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Year
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 1 years, or older
  2. * A patient who is a candidate for an ultrasound-guided peripheral intravenous catheter (midline catheters included) placement procedure using BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology as assessed per their clinician(s)
  3. * Able and willing to provide informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the subject
  1. * Any patient in whom ultrasound procedure might interfere with medical care or create undue hardship
  2. * Known, or suspected, allergy to materials contained in the BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology or accessories that may come in contact with the patient
  3. * Localized skin, tissue, or other clinical factors that would prevent completion of the ultrasound procedure
  4. * Previous medical history that would prevent completion of the ultrasound procedure

Contacts and Locations

Study Locations (Sites)

Brookdale University Hospital & Medical Center
Brooklyn, New York, 11212
United States
Allegheny Health Network Research Institute
Pittsburgh, Pennsylvania, 15212
United States

Collaborators and Investigators

Sponsor: Becton, Dickinson and Company

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-28
Study Completion Date2025-09-23

Study Record Updates

Study Start Date2025-03-28
Study Completion Date2025-09-23

Terms related to this study

Additional Relevant MeSH Terms

  • BD Prevue II for Peripheral Intravenous Catheter Placement